Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
FCAP First Capital Inc
BRMK Broadmark Realty Capital Inc
ABNB Airbnb Inc
AKTX Akari Therapeutics PLC
RPAY Repay Holdings Corp
BTU Peabody Energy Corp
MSFT Microsoft Corp
ASOMY ASOS PLC
GRBG Green Bridge Industries Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Postmarket

Last Trade
Delayed
$116.80
-0.0699 (-0.06%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$116.87
Day's Change
0.96 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
117.60
Day's Low
115.60
Volume
(Below Average)
Volume:
4,919,719

10-day average volume:
5,535,494
4,919,719

AbbVie Declares Quarterly Dividend

10:27 am ET September 10, 2021 (PR Newswire) Print

The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share.

The cash dividend is payable November 15, 2021 to stockholders of record at the close of business on October 15, 2021.

Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

https://c212.net/c/img/favicon.png?sn=CG01246&sd=2021-09-10

View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-301373397.html

SOURCE AbbVie

https://rt.prnewswire.com/rt.gif?NewsItemId=CG01246&Transmission_Id=202109101027PR_NEWS_USPR_____CG01246&DateId=20210910

comtex tracking

COMTEX_393115731/1005/2021-09-10T10:27:31

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.